Phreesia remains resilient, maintaining guidance and showing strong financial performance. Find out why I remain bullish on ...

Phreesia (NYSE:PHR – Free Report) had its price objective upped by Canaccord Genuity Group from $34.00 to $35.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, ...

Truist Financial analyst Jailendra Singh maintained a Buy rating on Phreesia (PHR – Research Report) today. The company’s shares closed ...

Q4 2025 Earnings Call Transcript March 12, 2025 Phreesia, Inc. beats earnings expectations. Reported EPS is $-0.11, ...

In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on Phreesia (PHR – Research Report), with a price target of ...

Phreesia (NYSE:PHR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports. They ...

Phreesia Inc (PHR) reports a 15% increase in revenue and maintains positive cash flow, despite facing macroeconomic challenges and competition. While the top- and bottom-line numbers for Phreesia ...

Phreesia Inc (PHR) reports a 15% increase in revenue and maintains positive cash flow, despite facing macroeconomic ...

First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer. Mr. Gandhi, you may begin. Thank you, operator. Good evening, and welcome to Phreesia's earnings conference call ...